| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.8 |